There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.
Cat No. | product name | ||
---|---|---|---|
L9200 | Drug Repurposing Compound Library | A unique collection of 4330 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | 4330 compounds |
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | 3158 compounds |
L1000 | Approved Drug Library | A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | 2863 compounds |
L3400 | Clinical Compound Library | A unique collection of 3480 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | 3480 compounds |
L3410 | Preclinical Compound Library | A unique collection of 709 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | 709 compounds |
L4210 | NMPA-Approved Drug Library | 1319 compounds | |
L4200 | FDA-Approved Drug Library | A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | 1729 compounds |